DarioHealth Corp (DRIO)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $12.98M
Last updated: Nov 17, 2026 at 4:04 PM ET
DarioHealth Corp (DRIO) Statistics
DarioHealth (DRIO) has a market cap of $12.98M and an enterprise value of $16.38M. Its share count is up 284.32% from a year earlier. It kept -159.85% of revenue as net income over the last 12 months.
Total Valuation
Enterprise value is 26.22% above the market cap, as debt exceeds cash.
| Market Cap | $12.98M |
|---|---|
| Enterprise Value | $16.38M |
| Latest price (Nov 17, 2026) | $1.15 |
Key Dates
The next earnings report is expected on Mar 17, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 17, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 12, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.7x and 0.2x. Its year-end P/S ranged from 1.7x to 18.3x from 2016 to 2025.
| P/S Ratio | 0.7x |
|---|---|
| Forward P/S | 0.6x |
| P/B Ratio | 0.2x |
Price Statistics
The stock is down 90.20% over 52 weeks and trades 75.94% below its 50-day average.
| Beta (1Y) | 0.16 |
|---|---|
| 52-Week Change | -90.20% |
| 1-Month Change | -74.39% |
| 3-Month Change | -83.94% |
| 6-Month Change | -85.98% |
| 5-Year Change | -99.08% |
| 10-Year Change | -99.77% |
| Total Return (1Y) | -90.20% |
| Total Return (3Y CAGR) | -63.57% |
| Total Return (5Y CAGR) | -67.57% |
| Return vs SPY (1Y) | -102.86% |
| Max Drawdown (1Y) | -91.79% |
| Max Drawdown (3Y) | -97.75% |
| Sharpe Ratio (1Y) | -2.78 |
| Correlation with SPY (1Y) | 0.02 |
| 50-Day Average | $4.78 |
| 200-Day Average | $7.19 |
| 52-Week Range | $1.09 to $14.77 |
| RSI (14 Days) | 17.6 |
| Average Volume (20 Days) | 88.35K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 4.20x current liabilities, and total debt is 0.44x shareholder equity.
| Current Ratio | 4.20x |
|---|---|
| Quick Ratio | 3.81x |
| Debt / Equity | 0.44x |
Returns and Efficiency
Return on invested capital is -22.28% over the last 12 months, against a 5-year average of -59.50%.
| Return on Equity (ROE) | -47.78% |
|---|---|
| Return on Assets (ROA) | -30.29% |
| Return on Invested Capital (ROIC) | -22.28% |
| Return on Capital Employed (ROCE) | -28.00% |
| ROE (5Y Average) | -78.09% |
| ROA (5Y Average) | -52.77% |
| ROIC (5Y Average) | -59.50% |
| Asset Turnover | 0.19x |
| Inventory Turnover | 2.47x |
| Receivables Turnover | 14.21x |
| Cash Conversion Cycle | -159 days |
Scores
DRIO has an Altman Z-Score of -6.08, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -6.08 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $21.30M over the last 12 months is down 13.86% from the 12 months before.
| Revenue | $21.30M |
|---|---|
| Revenue Growth (YoY) | -13.86% |
| Gross Profit | $12.34M |
| Operating Income | -$30.39M |
| Pretax Income | -$31.90M |
| Net Income | -$34.05M |
| EBITDA | -$26.82M |
| EBIT | -$28.91M |
| Reported EPS (TTM) | -$3.30 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 63.39% of the $112.43M in total assets.
| Cash and Equivalents | $27.84M |
|---|---|
| Total Debt | $31.25M |
| Net Debt | $3.40M |
| Net Debt Per Share | $0.28 |
| Working Capital | $29.31M |
| Shareholder Equity | $71.27M |
| Book Value Per Share | $5.91 |
| Tangible Book Value | -$684.00K |
| Total Assets | $112.43M |
| Total Liabilities | $41.16M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $122.00K of capital spending, operating cash flow left -$23.66M of free cash flow.
| Operating Cash Flow | -$23.53M |
|---|---|
| Capital Expenditures | $122.00K |
| Free Cash Flow | -$23.66M |
| FCF Per Share | -$2.41 |
| Depreciation and Amortization | $2.10M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -142.68%.
| Gross Margin | 57.93% |
|---|---|
| Operating Margin | -142.68% |
| Pretax Margin | -149.73% |
| Net Margin | -159.85% |
| EBITDA Margin | -125.87% |
| EBIT Margin | -135.72% |
| FCF Margin | -111.04% |
| Gross Margin (5Y Average) | 37.87% |
Growth
Revenue fell 6.84% a year over 3 years.
| Revenue Growth (3Y CAGR) | -6.84% |
|---|---|
| Revenue Growth (5Y CAGR) | +24.17% |
Dividends and Yields
DRIO does not pay a dividend. Its free cash flow yield is -170.56%.
| FCF Yield | -170.56% |
|---|---|
| Buyback Yield | 0.14% |
| Shareholder Yield | 0.14% |
Stock Splits
The last split was a 1-for-20 reverse split on Aug 28, 2025.
| Last Split Date | Aug 28, 2025 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:20 |
Analyst Forecast
Consensus estimates put revenue growth at 14.09% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +14.09% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About DRIO
What is DRIO's market cap?
DarioHealth has a market cap of $12.98M. Its enterprise value, which adds debt and subtracts cash, is $16.38M.
How many shares of DRIO are outstanding?
DarioHealth has 12.06M shares outstanding. The count is up 284.32% from a year earlier.
Does DRIO pay a dividend?
No. DarioHealth does not pay a dividend.
How much debt does DRIO have?
DarioHealth has $31.25M of total debt and $27.84M of cash and equivalents, a net debt position of $3.40M.
DRIO pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation